医学
肺功能
肺
功能(生物学)
儿科
进化生物学
内科学
生物
作者
X Zhang,Andrew Gray,Robert J. Hancox
出处
期刊:Thorax
[BMJ]
日期:2024-03-18
卷期号:: thorax-220436
标识
DOI:10.1136/thorax-2023-220436
摘要
Rationale Life course trajectories of lung function development and decline influence the risk for lung disease but are poorly documented. Objective To document lung function trajectories from childhood to mid-adult life. Methods We modelled forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC at ages 9, 11, 13, 15, 18, 21, 26, 32, 38 and 45 years from a population-based cohort using latent profile analysis to identify distinct subgroups of participants with similar lung function trajectories. Regression analyses were used to assess associations between the trajectories, early life factors and postbronchodilator airflow obstruction at age 45. Results Among 865 participants with ≥6 measures of lung function, we identified 10 distinct FEV 1 trajectories. Most were approximately parallel except for a childhood airway hyper-responsiveness-related persistently low trajectory (3% of study population); two accelerated-decline trajectories, one of which (8%) was associated with smoking and higher adult body mass index (BMI) and a catch-up trajectory (8%). Findings for FEV 1 /FVC trajectories were similar. Nine trajectories were identified for FVC: most were also approximately parallel except for a higher BMI-related accelerated-decline trajectory. The three FEV 1 trajectories leading to the lowest FEV 1 values comprised 19% of the cohort but contributed 55% of airflow obstruction at age 45. Conclusions Lung function trajectories to mid-adult life are largely established before adolescence, with a few exceptions: a childhood airway hyper-responsiveness-related persistently low trajectory, which starts low and gets worse with age, and accelerated adult decline trajectories associated with smoking and obesity. Adverse trajectories are associated with a high risk of airflow obstruction in mid-adult life.
科研通智能强力驱动
Strongly Powered by AbleSci AI